Combined medicine for preventing and/or repairing heart injuries caused by atmospheric pollution
A drug, prevention and control technology, applied in the direction of drug combination, anhydride/acid/halide active ingredients, medical preparations containing active ingredients, etc., can solve problems such as inconspicuous pollution control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Embodiment 1 A kind of combined medicine
[0044] The combination medicine of embodiment 1 comprises A component and B component, and the composition (by weight) of A component and B component is respectively as follows:
[0045] Component A: 4.32 parts of taurine, 0.012 part of coenzyme Q10;
[0046] B component: α-linolenic acid 0.66 part, linoleic acid 0.1728 part, eicosapentaenoic acid (EPA) 0.2196 part, docosahexaenoic acid (DHA) 0.144 part.
[0047] The weight ratio of A component and B component is about 3.62:1.
[0048] The preparation method of component A is as follows: mixing taurine and coenzyme Q10 to obtain component A.
[0049] The preparation method of component B is as follows: α-linolenic acid, linoleic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mixed to obtain component B.
Embodiment 2
[0050] Embodiment 2 A kind of combined medicine
[0051] The combination medicine of embodiment 2 comprises A component and B component, and the composition (by weight) of A component and B component is respectively as follows:
[0052] Component A: 2.16 parts of taurine, 0.006 part of coenzyme Q10;
[0053] B component: α-linolenic acid 0.99 part, linoleic acid 0.2592 part, eicosapentaenoic acid (EPA) 0.3294 part, docosahexaenoic acid (DHA) 0.216 part.
[0054] The weight ratio of A component and B component is about 1.21:1.
[0055] The preparation method of component A is as follows: mixing taurine and coenzyme Q10 to obtain component A.
[0056] The preparation method of component B is as follows: α-linolenic acid, linoleic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mixed to obtain component B.
Embodiment 3
[0057] Embodiment 3 A kind of combination medicine
[0058] The combination medicine of embodiment 3 comprises A component and B component, and the composition (by weight) of A component and B component is respectively as follows:
[0059] Component A: 6.48 parts of taurine, 0.018 part of coenzyme Q10;
[0060] B component: α-linolenic acid 0.33 part, linoleic acid 0.0864 part, eicosapentaenoic acid (EPA) 0.1098 part, docosahexaenoic acid (DHA) 0.072 part.
[0061] The weight ratio of A component and B component is about 10.86:1.
[0062] The preparation method of component A is as follows: mixing taurine and coenzyme Q10 to obtain component A.
[0063] The preparation method of component B is as follows: α-linolenic acid, linoleic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are mixed to obtain component B.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



